
FDA Approves First At-Home Cervical Cancer Screening Kit
The FDA has approved the first at-home cervical cancer screening kit, the Teal Wand™, offering a self-administered alternative to Pap smears.
Home » Industry Watch » Page 2
The FDA has approved the first at-home cervical cancer screening kit, the Teal Wand™, offering a self-administered alternative to Pap smears.
OpenAI has introduced HealthBench, a groundbreaking benchmark designed to assess the performance and safety of AI systems in healthcare settings.
Health Policy in 2025: Key Updates Impacting Payers and Administrators At A Glance A series of pivotal health policy shifts in early 2025 are reshaping
The FDA has approved Google’s Pixel Watch 3 for loss-of-pulse detection, marking a major step in wearable health tech.
On February 25, 2025, the Trump administration announced an Executive Order focused on enhancing price transparency in healthcare, a critical step toward empowering patients with clear and actionable pricing information. This initiative is expected to foster competition among providers and payers, ultimately aiming to reduce healthcare costs and improve patient access to care.
Could AI soon prescribe medications? H.R. 238 raises crucial questions about the role of artificial intelligence in healthcare decision-making.